Characterization of polyhormonal insulin-producing cells derived in vitro from human embryonic stem cells

Stem Cell Research

Volumn 12, Issue 1, 2014, Pages 194-208

  Bruin, Jennifer E ^a   Erener, Suheda ^a   Vela, Javier ^a   Hu, Xiaoke ^a   Johnson, James D ^a   Kurata, Harley T ^a   Lynn, Francis C ^a   Piret, James M ^b   Asadi, Ali ^a   Rezania, Alireza ^c   Kieffer, Timothy J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ARGININE; C PEPTIDE; CHEMOKINE RECEPTOR CXCR4; GLIBENCLAMIDE; GLUCAGON; GLUCOKINASE; GLUCOSE; GLUCOSE TRANSPORTER 1; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; MESSENGER RNA; RUBIDIUM; SULFONYLUREA RECEPTOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX6.1; TRANSCRIPTION FACTOR PDX 1;

ARTICLE; CELL DIFFERENTIATION; EMBRYONIC STEM CELL; ENDOCRINE CELL; FETUS; FETUS DEVELOPMENT; GLUCAGON RELEASE; GLUCOSE TRANSPORT; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN SITU HYBRIDIZATION; IN VITRO STUDY; INSULIN RELEASE; INSULIN SYNTHESIS; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL CULTURE; SYSTEMATIC REVIEW; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; C-PEPTIDE; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; ENDOCRINE CELLS; GLUCOKINASE; GLUCOSE TRANSPORTER TYPE 1; GLYBURIDE; HORMONES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN-SECRETING CELLS; KATP CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; SULFONYLUREA RECEPTORS;

EID: 84887925607     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.10.003     Document Type: Article

References (37)

1. Amps K., et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat. Biotechnol. 2011, 29(12):1132-1144.
2. Basford C.L., et al. The functional and molecular characterisation of human embryonic stem cell-derived insulin-positive cells compared with adult pancreatic beta cells. Diabetologia 2012, 55(2):358-371.
3. Bone H.K., et al. A novel chemically directed route for the generation of definitive endoderm from human embryonic stem cells based on inhibition of GSK-3. J. Cell Sci. 2011, 124(Pt 12):1992-2000.
4. Bonner-Weir S., Weir G.C. New sources of pancreatic beta-cells. Nat. Biotechnol. 2005, 23(7):857-861.
5. Bruin J.E., Kieffer T.J. Differentiation of human embryonic stem cells into pancreatic endocrine cells. Stem Cells and Cancer Stem Cells: Therapeutic Applications in Disease and Injury 2012, 192-206. Springer. M.A. Hayat (Ed.).
6. Bruin J.E., et al. Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice. Diabetologia 2013, 56(9):1987-1998.
7. Cai J., et al. Generation of homogeneous PDX1(+) pancreatic progenitors from human ES cell-derived endoderm cells. J. Mol. Cell Biol. 2010, 2(1):50-60.
8. Caron N.J., et al. A human embryonic stem cell line adapted for high throughput screening. Biotech. Bioeng. 2013, 110(10):2706-2716.
9. Chen S., et al. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat. Chem. Biol. 2009, 5(4):258-265.
10. Coppieters K.T., et al. Persistent glucose transporter expression on pancreatic beta cells from longstanding type 1 diabetic individuals. Diabetes Metab. Res. Rev. 2011, 27(8):746-754.
11. D'Amour K.A., et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 2006, 24(11):1392-1401.
12. De Vos A., et al. Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J. Clin. Invest. 1995, 96(5):2489-2495.
13. Donath M.Y., Halban P.A. Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 2004, 47(3):581-589.
14. Flagg T.P., et al. Transgenic overexpression of SUR1 in the heart suppresses sarcolemmal K(ATP). J. Mol. Cell. Cardiol. 2005, 39(4):647-656.
15. Fukayama M., et al. Development of human pancreas. Immunohistochemical study of fetal pancreatic secretory proteins. Differ.; Res. Biol. Divers. 1986, 31(2):127-133.
16. Furuta M., et al. Incomplete processing of proinsulin to insulin accompanied by elevation of Des-31,32 proinsulin intermediates in islets of mice lacking active PC2. J. Biol. Chem. 1998, 273(6):3431-3437.
17. Guo T., Hebrok M. Stem cells to pancreatic beta-cells: new sources for diabetes cell therapy. Endocr. Rev. 2009, 30(3):214-227.
18. Jiang J., et al. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 2007, 25(8):1940-1953.
19. Jiang W., et al. In vitro derivation of functional insulin-producing cells from human embryonic stem cells. Cell Res. 2007, 17(4):333-344.
20. Johansson K.A., et al. Temporal control of neurogenin3 activity in pancreas progenitors reveals competence windows for the generation of different endocrine cell types. Dev. Cell 2007, 12(3):457-465.
21. Kelly O.G., et al. Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells. Nat. Biotechnol. 2011, 29(8):750-756.
22. Kinkel M.D., et al. Cyp26 enzymes function in endoderm to regulate pancreatic field size. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(19):7864-7869.
23. Kroon E., et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 2008, 26(4):443-452.
24. Li J.B., et al. Decomposition of slide helix contributions to ATP-dependent inhibition of Kir6.2 channels. J. Biol. Chem. 2013, 288(32):23038-23049.
25. MacDonald P.E., Joseph J.W., Rorsman P. Glucose-sensing mechanisms in pancreatic beta-cells. Philos. Trans. R. Soc. B-Biol. Sci. 2005, 360(1464):2211-2225.
26. Mathis D., Vence L., Benoist C. beta-Cell death during progression to diabetes. Nature 2001, 414(6865):792-798.
27. Mfopou J.K., et al. Noggin, retinoids, and fibroblast growth factor regulate hepatic or pancreatic fate of human embryonic stem cells. Gastroenterology 2010, 138(7):2233-2245. (2245 e1-14).
28. Nostro M.C., et al. Stage-specific signaling through TGFbeta family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development 2011, 138(5):861-871.
29. Ostrom M., et al. Retinoic acid promotes the generation of pancreatic endocrine progenitor cells and their further differentiation into beta-cells. PLoS ONE 2008, 3(7):e2841.
30. Rezania A., et al. Production of functional glucagon-secreting alpha-cells from human embryonic stem cells. Diabetes 2011, 60(1):239-247.
31. Rezania A., et al. Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes 2012, 61(8):2016-2029.
32. Rezania A., et al. Enrichment of human embryonic stem cell-derived NKX6.1-expressing pancreatic progenitor cells accelerates the maturation of insulin-secreting cells in vivo. Stem Cells 2013, (Epub ahead of print). 10.1002/stem.1489.
33. Riedel M.J., et al. Immunohistochemical characterization of insulin/glucagon co-expressing cells in the developing human pancreas. Diabetologia 2011, 55(2):372-381.
34. Schulze H.G., et al. Assessing differentiation status of human embryonic stem cells noninvasively using Raman microspectroscopy. Anal. Chem. 2010, 82(12):5020-5027.
35. Tuduri E., Bruin J.E., Kieffer T.J. Restoring insulin production for type 1 diabetes. J. Diabetes 2012, 4(4):319-331.
36. Xu X., Browning V.L., Odorico J.S. Activin, BMP and FGF pathways cooperate to promote endoderm and pancreatic lineage cell differentiation from human embryonic stem cells. Mech. Dev. 2011, 128(7-10):412-427.
37. Zhu X., et al. Severe block in processing of proinsulin to insulin accompanied by elevation of des-64,65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(16):10299-10304.